Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Alto NM, Shao F, Lazar CS, Brost RL, Chua G, Mattoo S, McMahon SA, Ghosh P, Hughes TR, Boone C, Dixon JE: Identification of a bacterial type III effector family with G protein mimicry functions
Our approach is patient-centered, and we work closely with you to determine the most appropriate treatment plan based on your health status and specific requirements
Talk to your provider about safe limits for you
A pilot study involving 16 patients with distal IBD reported a mean 60% reduction in disease severity after 12 weeks of rectal GHK-Cu treatment, as assessed by endoscopic, histopathological, and symptomatic evaluations (Pickart, 2008)
Rest assured, the formulation, purity and quality remain exactly same as standards
Most therapeutic peptides have relatively short half-lives minutes to hours which is why consistent daily dosing is required during an active cycle
